For the Inventor, By the Inventor

Enter assignee name

Little Falls, NJ, United States of America

Hoffmann-la Roche Inc.

USPTO Granted Patents = 4,943

CIPO Patents = 1

EPO Patents = 6

Trademarks = 69

Forward Citations = 44,675

Loading Chart...

Loading Chart...

3,609 inventors (with patents filed for the assignee):

Matthias Heinrich Nettekoven (126 out of 130 patents)

Milan R Uskokovic (113 out of 118 patents)

Bernd Kuhn (109 out of 113 patents)

4. Christian Klein (101 out of 170 patents)

5. Roger David Norcross (83 out of 92 patents)

6. Emmanuel Pinard (82 out of 88 patents)

7. Perry Rosen (82 out of 87 patents)

8. Gabriel G Saucy (81 out of 85 patents)

9. Georg Jaeschke (79 out of 83 patents)

10. Hans Hilpert (77 out of 87 patents)

11. Werner Neidhart (77 out of 79 patents)

12. Mark Rogers-Evans (76 out of 85 patents)

13. Emilio Kyburz (75 out of 75 patents)

14. Hasane Ratni (74 out of 87 patents)

15. Peter Mohr (73 out of 83 patents)

Core Competencies:

Autoimmune Disease Treatment

EGFR Inhibitors

Machine Learning Models

Bispecific Antibodies

Digital Biomarkers

Pharmaceutical Formulations

Endoscopic Disease Assessment

Genetic Markers

Heterocyclic Compounds

Antibody Activity Determination

Liquid Transfer Devices

Intelligent Workflow Analysis

4,943 patents: Sort by Forward Citations

1. 12491134 - Medical delivery device (2025-12-09),

2. 12486273 - Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune disease (2025-12-02),

3. 12479883 - Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform (2025-11-25),

4. 12479849 - EGFR inhibitors for the treatment of cancer (2025-11-25),

5. 12479637 - Closure system and kit (2025-11-25),

6. 12478552 - Closure system and kit (2025-11-25),

7. 12468872 - Low volume filling of a liquid into a container (2025-11-11),

8. 12465551 - Closure system and kit (2025-11-11),

9. 12462938 - Machine-learning model for generating hemophilia pertinent predictions using sensor data (2025-11-04),

10. 12462937 - Intelligent workflow analysis for treating covid-19 using exposable cloud-based registries (2025-11-04),

11. 12461109 - Vitro prediction of in vivo half-life (2025-11-04),

12. 12461075 - Separation method and system for preparing target compounds (2025-11-04),

13. 12460015 - Pharmaceutical formulation comprising aqueous solution of antibody (2025-11-04),

14. 12459947 - Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crystalline forms thereof (2025-11-04),

15. 12458567 - Adapter for connecting a dispenser to a container (2025-11-04),

Hoffmann-LaRoche Inc. is a global healthcare company focused on improving people's lives. With a strong presence in pharmaceuticals and diagnostics, Roche's innovative solutions help diagnose, prevent, and treat various diseases. The company aims to develop personalized medicine and provide patients with better access to healthcare. Roche values scientific excellence and collaborates with partners to accelerate medical advancements.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4,943 Patents

#1 in Little Falls, NJ

#4 in New Jersey

#86 in US

#181 in the World

Little Falls, NJ, United States of America

Hoffmann-la Roche Inc.

Forward Citations = 44,675

3,609 inventors:

Matthias Heinrich Nettekoven (126 out of 130 patents)

Milan R Uskokovic (113 out of 118 patents)

Bernd Kuhn (109 out of 113 patents)

4. Christian Klein (101 out of 170 patents)

5. Roger David Norcross (83 out of 92 patents)

Please report any incorrect information to support@idiyas.com

Loading…